3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year Post author:Sam Post published:November 20, 2017 Post category:BioPharma Investors have had a decent year, but some have much to be grateful for this Thanksgiving. Source: BioSpace You Might Also Like Tiny New York Biotech With Ties To Massachusetts, Syntimmune, Gets A $50 Million Boost June 20, 2017 Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection August 24, 2017 Novartis AG to Shed Another 500 Jobs, Add 350 High-Tech Jobs May 18, 2017
Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection August 24, 2017